130 related articles for article (PubMed ID: 11922675)
1. Interaction of the myogenic determination factor myogenin with E12 and a DNA target: mechanism and kinetics.
Spinner DS; Liu S; Wang SW; Schmidt J
J Mol Biol; 2002 Mar; 317(3):431-45. PubMed ID: 11922675
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activation of the myogenin gene by MEF2-mediated recruitment of myf5 is inhibited by adenovirus E1A protein.
Johanson M; Meents H; Ragge K; Buchberger A; Arnold HH; Sandmöller A
Biochem Biophys Res Commun; 1999 Nov; 265(1):222-32. PubMed ID: 10548518
[TBL] [Abstract][Full Text] [Related]
3. MyoD-E12 heterodimers and MyoD-MyoD homodimers are equally stable.
Maleki SJ; Royer CA; Hurlburt BK
Biochemistry; 1997 Jun; 36(22):6762-7. PubMed ID: 9184158
[TBL] [Abstract][Full Text] [Related]
4. Monoclonal antimyogenin antibodies define epitopes outside the bHLH domain where binding interferes with protein-protein and protein-DNA interactions.
Wright WE; Dac-Korytko I; Farmer K
Dev Genet; 1996; 19(2):131-8. PubMed ID: 8900045
[TBL] [Abstract][Full Text] [Related]
5. Role of DNA sequence in the binding specificity of synthetic basic-helix-loop-helix domains.
Beltran AC; Dawson PE; Gottesfeld JM
Chembiochem; 2005 Jan; 6(1):104-13. PubMed ID: 15593070
[TBL] [Abstract][Full Text] [Related]
6. Activation of muscle-specific transcription by myogenic helix-loop-helix proteins.
Olson E
Symp Soc Exp Biol; 1992; 46():331-41. PubMed ID: 1341046
[TBL] [Abstract][Full Text] [Related]
7. A conserved enhancer element that drives FGF4 gene expression in the embryonic myotomes is synergistically activated by GATA and bHLH proteins.
Iwahori A; Fraidenraich D; Basilico C
Dev Biol; 2004 Jun; 270(2):525-37. PubMed ID: 15183731
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the DNA-binding properties of MyoD, myogenin, and E12 by fluorescence anisotropy.
Maleki SJ; Royer CA; Hurlburt BK
Biochemistry; 2002 Sep; 41(35):10888-94. PubMed ID: 12196028
[TBL] [Abstract][Full Text] [Related]
9. Role of basic-helix-loop-helix transcription factors in Sertoli cell differentiation: identification of an E-box response element in the transferrin promoter.
Chaudhary J; Cupp AS; Skinner MK
Endocrinology; 1997 Feb; 138(2):667-75. PubMed ID: 9003001
[TBL] [Abstract][Full Text] [Related]
10. Multimeric structures influence the binding activity of bHLH muscle regulatory factors.
Wright WE; Catala F; Farmer K
Symp Soc Exp Biol; 1992; 46():79-87. PubMed ID: 1341052
[TBL] [Abstract][Full Text] [Related]
11. Arginine (348) is a major determinant of the DNA binding specificity of transcription factor E12.
Sieber M; Allemann RK
Biol Chem; 1998 Jun; 379(6):731-5. PubMed ID: 9687024
[TBL] [Abstract][Full Text] [Related]
12. High-level expression and purification of MyoD, myogenin, and E12.
Maleki SJ; Hurlburt BK
Protein Expr Purif; 1997 Feb; 9(1):91-9. PubMed ID: 9116507
[TBL] [Abstract][Full Text] [Related]
13. Cooperative activation of atrial naturetic peptide promoter by dHAND and MEF2C.
Zang MX; Li Y; Xue LX; Jia HT; Jing H
J Cell Biochem; 2004 Dec; 93(6):1255-66. PubMed ID: 15486975
[TBL] [Abstract][Full Text] [Related]
14. Dual promoter structure of ZFP106: regulation by myogenin and nuclear respiratory factor-1.
Grasberger H; Ye H; Mashima H; Bell GI
Gene; 2005 Jan; 344():143-59. PubMed ID: 15656981
[TBL] [Abstract][Full Text] [Related]
15. Acquisition of myogenic specificity through replacement of one amino acid of MASH-1 and introduction of an additional alpha-helical turn.
Dezan C; Meierhans D; Künne AG; Allemann RK
Biol Chem; 1999 Jun; 380(6):705-10. PubMed ID: 10430036
[TBL] [Abstract][Full Text] [Related]
16. Thermodynamics of b-HLH-LZ protein binding to DNA: the energetic importance of protein-DNA contacts in site-specific E-box recognition by the complete gene product of the Max p21 transcription factor.
Meier-Andrejszki L; Bjelić S; Naud JF; Lavigne P; Jelesarov I
Biochemistry; 2007 Oct; 46(43):12427-40. PubMed ID: 17915948
[TBL] [Abstract][Full Text] [Related]
17. Functional redundancy of the muscle-specific transcription factors Myf5 and myogenin.
Wang Y; Schnegelsberg PN; Dausman J; Jaenisch R
Nature; 1996 Feb; 379(6568):823-5. PubMed ID: 8587605
[TBL] [Abstract][Full Text] [Related]
18. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
[TBL] [Abstract][Full Text] [Related]
19. The NMR solution structure of a mutant of the Max b/HLH/LZ free of DNA: insights into the specific and reversible DNA binding mechanism of dimeric transcription factors.
Sauvé S; Tremblay L; Lavigne P
J Mol Biol; 2004 Sep; 342(3):813-32. PubMed ID: 15342239
[TBL] [Abstract][Full Text] [Related]
20. Preferential binding of MyoD-E12 versus myogenin-E12 to the murine sarcoma virus enhancer in vitro.
Czernik PJ; Peterson CA; Hurlburt BK
J Biol Chem; 1996 Apr; 271(15):9141-9. PubMed ID: 8621566
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
